Literature DB >> 29133567

Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission.

Natalia Blanco1, Anthony D Harris1, Clare Rock2, J Kristie Johnson3, Lisa Pineles1, Robert A Bonomo4,5,6, Arjun Srinivasan7, Melinda M Pettigrew8, Kerri A Thom9.   

Abstract

Multidrug-resistant (MDR) Acinetobacter baumannii, associated with broad-spectrum antibiotic use, is an important nosocomial pathogen associated with morbidity and mortality. This study aimed to investigate the prevalence of MDR A. baumannii perirectal colonization among adult patients upon admission to the intensive care unit (ICU) over a 5-year period and to identify risk factors and outcomes associated with colonization. A retrospective cohort analysis of patients admitted to the medical intensive care unit (MICU) and surgical intensive care unit (SICU) at the University of Maryland Medical Center from May 2005 to September 2009 was performed using perirectal surveillance cultures on admission. Poisson and logistic models were performed to identify associated risk factors and outcomes. Four percent of the cohort were positive for MDR A. baumannii at ICU admission. Among patients admitted to the MICU, those positive for MDR A. baumannii at admission were more likely to be older, to have received antibiotics before ICU admission, and to have shorter length of stay in the hospital prior to ICU admission. Among patients admitted to the SICU, those colonized were more likely to have at least one previous admission to our hospital. Patients positive for MDR A. baumannii at ICU admission were 15.2 times more likely to develop a subsequent positive clinical culture for A. baumannii and 1.4 times more likely to die during the current hospitalization. Risk factors associated with MDR A. baumannii colonization differ by ICU type. Colonization acts as a marker of disease severity and of risk of developing a subsequent Acinetobacter infection and of dying during hospitalization. Therefore, active surveillance could guide empirical antibiotic selection and inform infection control practices.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Acinetobacter; colonization; multidrug resistance

Mesh:

Substances:

Year:  2017        PMID: 29133567      PMCID: PMC5740370          DOI: 10.1128/AAC.01631-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Incidence and prevalence of multidrug-resistant acinetobacter using targeted active surveillance cultures.

Authors:  Lisa L Maragakis; Margaret G Tucker; Redonda G Miller; Karen C Carroll; Trish M Perl
Journal:  JAMA       Date:  2008-06-04       Impact factor: 56.272

3.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

Review 4.  Multiresistant Acinetobacter baumannii infections: epidemiology and management.

Authors:  José Garnacho-Montero; Rosario Amaya-Villar
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

5.  Surveillance cultures growing carbapenem-Resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study.

Authors:  Rachel Latibeaudiere; Rossana Rosa; Panthipa Laowansiri; Kristopher Arheart; Nicholas Namias; L Silvia Munoz-Price
Journal:  Clin Infect Dis       Date:  2014-10-28       Impact factor: 9.079

6.  Four years of surveillance cultures at a long-term acute care hospital.

Authors:  L Silvia Munoz-Price; Alexander Stemer
Journal:  Infect Control Hosp Epidemiol       Date:  2010-01       Impact factor: 3.254

7.  Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii.

Authors:  X Corbella; M Pujol; J Ayats; M Sendra; C Ardanuy; M A Domínguez; J Liñares; J Ariza; F Gudiol
Journal:  Clin Infect Dis       Date:  1996-08       Impact factor: 9.079

8.  Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Authors:  Rebecca H Sunenshine; Marc-Oliver Wright; Lisa L Maragakis; Anthony D Harris; Xiaoyan Song; Joan Hebden; Sara E Cosgrove; Ashley Anderson; Jennifer Carnell; Daniel B Jernigan; David G Kleinbaum; Trish M Perl; Harold C Standiford; Arjun Srinivasan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes.

Authors:  A Abbo; Y Carmeli; S Navon-Venezia; Y Siegman-Igra; M J Schwaber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

10.  Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002-2006.

Authors:  M Wadl; K Heckenbach; I Noll; S Ziesing; W Pfister; J Beer; S Schubert; T Eckmanns
Journal:  Infection       Date:  2010-01-27       Impact factor: 3.553

View more
  17 in total

1.  Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii.

Authors:  Inga V Leus; Jon W Weeks; Vincent Bonifay; Lauren Smith; Sophie Richardson; Helen I Zgurskaya
Journal:  J Bacteriol       Date:  2018-06-11       Impact factor: 3.490

2.  Multidrug-Resistant Acinetobacter baumannii - The Modern Menace: A Retrospective Study in a Tertiary Hospital in Mangalore.

Authors:  K C Ashuthosh; Ashwini Hegde; Pooja Rao; Radhakrishna Manipura
Journal:  Infect Drug Resist       Date:  2020-07-07       Impact factor: 4.003

3.  Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon.

Authors:  Tania Nawfal Dagher; Charbel Al-Bayssari; Selma Chabou; Nadine Antar; Seydina M Diene; Eid Azar; Jean-Marc Rolain
Journal:  BMC Microbiol       Date:  2019-02-02       Impact factor: 3.605

4.  Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumannii.

Authors:  S H Ardehali; T Azimi; Fatemeh Fallah; M Owrang; N Aghamohammadi; L Azimi
Journal:  New Microbes New Infect       Date:  2019-04-16

5.  Rapid screening and early precautions for carbapenem-resistant Acinetobacter baumannii carriers decreased nosocomial transmission in hospital settings: a quasi-experimental study.

Authors:  Norihisa Yamamoto; Shigeto Hamaguchi; Yukihiro Akeda; Pitak Santanirand; Narong Chaihongsa; Suntariya Sirichot; Suwichak Chiaranaicharoen; Hideharu Hagiya; Kouji Yamamoto; Anusak Kerdsin; Kazuhisa Okada; Hisao Yoshida; Shigeyuki Hamada; Kazunori Oishi; Kumthorn Malathum; Kazunori Tomono
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-27       Impact factor: 4.887

6.  The Landscape of Phenotypic and Transcriptional Responses to Ciprofloxacin in Acinetobacter baumannii: Acquired Resistance Alleles Modulate Drug-Induced SOS Response and Prophage Replication.

Authors:  Edward Geisinger; Germán Vargas-Cuebas; Nadav J Mortman; Sapna Syal; Yunfei Dai; Elizabeth L Wainwright; David Lazinski; Stephen Wood; Zeyu Zhu; Jon Anthony; Tim van Opijnen; Ralph R Isberg
Journal:  mBio       Date:  2019-06-11       Impact factor: 7.867

7.  Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah.

Authors:  Amanda R Smith; Maureen Vowles; Roberta Z Horth; Lori Smith; Linda Rider; Jennifer M Wagner; Anna Sangster; Erin L Young; Hailey Schuckel; James Stewart; Randon J Gruninger; Alessandro Rossi; Kelly F Oakeson; Allyn K Nakashima
Journal:  Am J Infect Control       Date:  2020-11-17       Impact factor: 2.918

8.  Subtypes, resistance and virulence platforms in extended-drug resistant Acinetobacter baumannii Romanian isolates.

Authors:  Irina Gheorghe; Ilda Czobor Barbu; Marius Surleac; Ionela Sârbu; Laura Ioana Popa; Simona Paraschiv; Yu Feng; Veronica Lazăr; Mariana Carmen Chifiriuc; Dan Oţelea; Zong Zhiyong
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

Review 9.  Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment.

Authors:  Soroosh Monem; Beata Furmanek-Blaszk; Adrianna Łupkowska; Dorota Kuczyńska-Wiśnik; Karolina Stojowska-Swędrzyńska; Ewa Laskowska
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

10.  Detection of csgA gene in carbapenem-resistant Acinetobacter baumannii strains and targeting with Ocimum sanctum biocompounds.

Authors:  Saishree R Anchana; Smiline A S Girija; Shoba Gunasekaran; Vijayashree J Priyadharsini
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.